{"doi":"10.1091/mbc.9.10.2715","title":"Use of a β1 Integrin-deficient Human T Cell to Identify β1 Integrin Cytoplasmic Domain Sequences Critical for Integrin Function","abstract":"<jats:p>T cell activation rapidly and transiently regulates the functional activity of integrin receptors. Stimulation of CD3/T cell receptor, CD2 or CD28, as well as activation with phorbol esters, can induce within minutes an increase in β1 integrin-mediated adhesion of T cells to fibronectin. In this study, we have produced and utilized a mutant of the Jurkat T cell line, designated A1, that lacks protein and mRNA expression of the β1 integrin subunit but retains normal levels of CD2, CD3, and CD28 on the cell surface. Activation-dependent adhesion of A1 cells to fibronectin could be restored upon transfection of a wild-type human β1 integrin cDNA. Adhesion induced by phorbol 12-myristate 13-acetate-, CD3-, CD2-, and CD28 stimulation did not occur if the carboxy-terminal five amino acids of the β1 tail were truncated or if either of two well-conserved NPXY motifs were deleted. Scanning alanine substitutions of the carboxy-terminal five amino acids demonstrated a critical role for the tyrosine residue at position 795. The carboxy-terminal truncation and the NPXY deletions also reduced adhesion induced by direct stimulation of the β1 integrin with the activating β1 integrin-specific mAb TS2/16, although the effects were not as dramatic as observed with the other integrin-activating signals. These results demonstrate a vital role for the amino-terminal NPXY motif and the carboxy-terminal end of the β1 integrin cytoplasmic domain in activation-dependent regulation of integrin-mediated adhesion in T cells. Furthermore, the A1 cell line represents a valuable new cellular reagent for the analysis of β1 integrin structure and function in human T cells.</jats:p>","journal":"Molecular Biology of the Cell","year":1998,"id":19760,"datarank":2.181474506811857,"base_score":3.713572066704308,"endowment":3.713572066704308,"self_citation_contribution":0.5570358100056463,"citation_network_contribution":1.6244386968062106,"self_endowment_contribution":0.5570358100056463,"citer_contribution":1.6244386968062106,"corpus_percentile":null,"corpus_rank":null,"citation_count":40,"citer_count":29,"citers_with_citation_signal":27,"citers_with_endowment":27,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":105734,"name":"Estelle S. Harris","orcid":null,"position":1,"is_corresponding":false},{"id":132857,"name":"Cheryl L. Dell","orcid":null,"position":2,"is_corresponding":false},{"id":132858,"name":"Jeffrey Skronek","orcid":null,"position":3,"is_corresponding":false},{"id":132859,"name":"Elizabeth Hasse","orcid":null,"position":4,"is_corresponding":false},{"id":132860,"name":"Pamela J. Reynolds","orcid":null,"position":5,"is_corresponding":false},{"id":132861,"name":"Stephen W. Hunt","orcid":null,"position":6,"is_corresponding":false},{"id":132862,"name":"Yoji Shimizu","orcid":null,"position":7,"is_corresponding":false},{"id":132856,"name":"Nadine C. Romzek","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":3.713572066704308,"endowment":3.713572066704308,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"9763439","pmcid":"PMC25547","openalex_id":"https://openalex.org/W2100458140","authors":[],"funders":[{"funder_name":"NIAID NIH HHS","grant_id":"R56 AI038474","title":null},{"funder_name":"NIAID NIH HHS","grant_id":"R01 AI038474","title":null},{"funder_name":"NIAID NIH HHS","grant_id":"AI-38474","title":null}],"total_grants":3,"fwci":1.5013,"citation_percentile":0.80265487,"influential_citations":2,"citation_trend":[{"year":2013,"count":1},{"year":2014,"count":3},{"year":2015,"count":2},{"year":2016,"count":1},{"year":2021,"count":1}],"oa_status":"green","license":null,"oa_locations":[{"url":"https://europepmc.org/articles/pmc25547?pdf=render","host_type":"GREEN"},{"url":"https://doi.org/10.1091/mbc.9.10.2715","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/9763439","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/25547","host_type":"repository"}],"fields_of_study":["Cell Adhesion Molecules Research","Immunotherapy and Immune Responses","T-cell and B-cell Immunology","Biology"],"mesh_terms":["Amino Acid Sequence","Base Sequence","Cell Adhesion","Fibronectins","Humans","Molecular Sequence Data","Recombinant Proteins","T-Lymphocytes","Transfection","Tyrosine","Mutagenesis, Site-Directed","Sequence Alignment","Point Mutation","DNA Primers","Integrin beta1","Jurkat Cells"],"keywords":["CD49c","Integrin, beta 6","Integrin","Biology","Integrin alpha M","Collagen receptor","Cell biology","Cell adhesion","Molecular biology","Biochemistry","Receptor","Cell","Flow cytometry"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-04T05:45:07.564997Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}